MOG and myeloid sarcoma: Interestingly, in two olfactory detection tests, we observed that in mice immunized with MOG develop olfactory dysfunction at onset of disease and at chronic stage of disease, similar to what has been described in MS [3, 8, 36–38], but also in our EAE mouse model through two olfactory detection tests.